However, individuals meeting the genetic criteria for FSHD express stable DUX4-fl mRNA and protein in their skeletal muscles, which aberrantly activate an embryonic gene expression profile [9, 17, 18, 26, 27], ultimately leading to FSHD pathophysiology. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.